Novo Holdings A/S as of Dec. 31, 2025
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 24 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 12.5 | $160M | 3.5M | 45.89 | |
| Edgewise Therapeutics (EWTX) | 10.3 | $133M | 5.4M | 24.82 | |
| Asml Holding N V N Y Registry Shs (ASML) | 9.5 | $122M | 114k | 1069.86 | |
| Mirum Pharmaceuticals (MIRM) | 7.8 | $100M | 1.3M | 78.99 | |
| salesforce (CRM) | 6.8 | $88M | 330k | 264.91 | |
| Crinetics Pharmaceuticals In (CRNX) | 5.9 | $76M | 1.6M | 46.55 | |
| Miragen Therapeutics (VRDN) | 5.8 | $74M | 2.4M | 31.12 | |
| Maplight Therapeutics (MPLT) | 5.0 | $65M | 3.7M | 17.57 | |
| Zenas Biopharma (ZBIO) | 4.1 | $53M | 1.5M | 36.31 | |
| Pharvaris N V (PHVS) | 3.8 | $49M | 1.8M | 27.75 | |
| Apogee Therapeutics (APGE) | 3.3 | $43M | 570k | 75.48 | |
| Vaxcyte (PCVX) | 3.3 | $42M | 916k | 46.14 | |
| BioMarin Pharmaceutical (BMRN) | 3.0 | $39M | 660k | 59.43 | |
| Arrivent Biopharma (AVBP) | 3.0 | $39M | 1.9M | 20.12 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.9 | $38M | 257k | 146.58 | |
| Insmed Com Par $.01 (INSM) | 2.7 | $35M | 200k | 174.04 | |
| Celldex Therapeutics Com New (CLDX) | 2.5 | $33M | 1.2M | 27.16 | |
| 4d Molecular Therapeutics In (FDMT) | 2.1 | $27M | 3.7M | 7.50 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 1.9 | $25M | 2.0M | 12.52 | |
| Enliven Therapeutics (ELVN) | 1.8 | $23M | 1.5M | 15.40 | |
| Valneva Se Sponsored Ads (VALN) | 1.6 | $20M | 2.3M | 8.82 | |
| Lanzatech Global Com New (LNZA) | 0.2 | $2.2M | 158k | 13.76 | |
| Marqeta Class A Com (MQ) | 0.2 | $2.1M | 442k | 4.75 | |
| Io Biotech (IOBT) | 0.1 | $1.5M | 2.5M | 0.61 |
